PMID: 7034019Nov 1, 1981Paper

Is PGI2 arrhythmogenic? Investigations on ouabain induced arrhythmias in cats

Prostaglandins and Medicine
H J Mest, W Förster


The present study investigated the effect of PGI2 on ouabain induced arrhythmias in cats. PGI2 was infused at a dose of 1.0, 2.0 and 5.0 microgram/kg . min. PGI2 in a dose of 1.0 microgram/kg . min was without any antiarrhythmic effect. Infusions of 2.0 and 5.0 microgram/kg . min PGI2 in 3 of 10 and 7 of 10 animals, respectively, converted the ouabain induced arrhythmias into a sinus rhythm. The duration of the antiarrhythmic effect after infusion of 2.0 microgram/kg . min lasted about 21 min, whereas the higher dose (5.0 microgram/kg . min) had a shorter effect (about 2 min). Under these conditions and doses the systolic blood pressure decreased between 35% and 39% and the diastolic blood pressure was reduced by about 50%. Thus PGI2 showed when used in the given dose range, an antiarrhythmic effect on ouabain induced arrhythmias in cats. The importance of dosage, methods and species is here discussed.


Jan 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·P C IsaksonP Needleman
Feb 1, 1978·Circulation Research·T M FitzpatrickP A Kot
Sep 1, 1979·Prostaglandins and Medicine·R K DixT Lawrence
Dec 1, 1973·European Journal of Pharmacology·G J Kelliher, T M Glenn
May 1, 1972·European Journal of Pharmacology·W G ZijlstraA J Vergroesen


Nov 1, 1988·Journal of Pharmacological Methods·T S RaoS C Manchanda
Jul 1, 1987·Prostaglandins, Leukotrienes, and Medicine·J BeitzH J Mest
Jul 1, 1995·Prostaglandins, Leukotrienes, and Essential Fatty Acids·H J MestC Giessler
Mar 1, 1989·Prostaglandins, Leukotrienes, and Essential Fatty Acids·A BeitzH J Mest
Sep 1, 1982·TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·W E Lönnig
May 1, 1985·TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·W Gottschalk
Jan 1, 1985·Acta Medica Scandinavica. Supplementum·H Vapaatalo

Related Concepts

Cardiac Arrhythmia
Diastolic Blood Pressure
Felis catus
Dose-Response Relationship, Drug
Pulse Rate

Related Feeds


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.